title: Dodging a dogma: is treating beyond progression beneficial?
authors: The University of Texas MD Anderson Cancer Center, Unit 455, Houston, TX 77030, USA. anaing@mdanderson.org
authors: Aung
authors: A
authors: Naing
authors: Razelle
authors: R
authors: Kurzrock
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents